Biotech bigwig Gilead Sciences Inc. GILD is likely to beat expectations when it reports results for the second quarter on Jul 25, after the market closes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,